Dachaigh › Carcinoma Urothelial (Cealla Transitional) › Massachusetts › Boston
Sgrùdaidhean clionaigeach Carcinoma Urothelial (Cealla Transitional) ann an Boston, MA
Tha aon sgrùdadh airson Carcinoma Urothelial (Cealla Transitional) a’ lorg phàirtichean aig làrach ann no faisg air Boston. Fosglaidh e gus faicinn cò as urrainn pàirt a ghabhail agus mar a chuireas tu fios air an sgioba.
Teacsa sgrùdaidh oifigeil (Beurla)
A’ fastadh airson sgrùdadh an seo? Seall e aig mullach na duilleige seo — $99 airson 30 latha →
Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
A’ fastadhÌre 1
- Exelixis Clinical Site #7, Boston
A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors
A’ fastadhÌre 1
- Brigham and Women's Hospital, Boston
- Dana-Farber Cancer Institute, Boston
uTRACT Jelmyto Registry: A Registry of Patients With Upper Tract Urothelial Cancer (UTUC) Treated With Jelmyto
A’ fastadhSgrùdadh amharc
- Mass General Brigham, Boston
- Brigham and Women's Hospital, Boston
Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis
A’ fastadhÌre 1/2
- Tufts Medical Center, Boston
A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
A’ fastadhÌre 3
- Massachusetts General Hospital, Boston
Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors
A’ fastadhÌre 1
- Dana Farber Cancer Institute, Boston
Study of DCC-2812 in Participants With Advanced Genitourinary Cancers
A’ fastadhÌre 1
- Dana-Farber Cancer Institute, Boston
An Open-label Study to Investigate the Efficacy and Safety of Dato-DXd + Rilvegostomig vs SoC in Adult Participants With High-risk MIUC
A’ fastadhÌre 3
- Research Site, Boston
This is a Phase 1 Trial of ZM008, an Anti-LLT1 Antibody, Used as Single Agent Followed by Combination Treatment With Toripalimab in Patients With Advanced Solid Tumors
A’ fastadhÌre 1
- Dana Farber Cancer Institute, Boston
Management of Cisplatin-Ineligible Patients With Metastatic Bladder Cancer and The Role of Geriatric Assessments
A’ fastadhSgrùdadh amharc
- Dana-Farber Cancer Institute, Boston
Sacituzumab Govitecan Plus EV in Metastatic UC
A’ fastadhÌre 1/2
- Dana Farber Cancer Institute, Boston
Sgrùdaidhean Carcinoma Urothelial (Cealla Transitional) ann am bailtean eile
- Nashville, TN23 sgrùdaidhean
- New York City, NY22 sgrùdaidhean
- Houston, TX19 sgrùdaidhean
- Dallas, TX18 sgrùdaidhean
- Edison, NJ18 sgrùdaidhean
- Los Angeles, CA17 sgrùdaidhean
- Queens, NY15 sgrùdaidhean
- Chicago, IL14 sgrùdaidhean
- Arlington, VA12 sgrùdaidhean
- San Antonio, TX11 sgrùdadh
- Austin, TX10 sgrùdaidhean
- Orange, CA10 sgrùdaidhean
Sgrùdaidhean eile ann an Boston
- Aillse a' bhroilleach112 sgrùdaidhean
- Aillse Sgamhain Neo-chealla-beag90 sgrùdaidhean
- Aillse (gach seòrsa)85 sgrùdaidhean
- Ailse metastatach63 sgrùdaidhean
- Aillse colorectal63 sgrùdaidhean
- Ailseachadh nan Sgamhan62 sgrùdaidhean
- Cancer Ovarian61 sgrùdaidhean
- Aillse Prostata59 sgrùdaidhean
- Depression52 sgrùdaidhean
- Ailse Endometrial50 sgrùdaidhean
- Fàilligeadh a' Chridhe44 sgrùdaidhean
- Leukemia myeloid geur44 sgrùdaidhean
Bho ClinicalTrials.gov, dàta air a thogail 6 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.